Skip to main content
. 2019 May 21;72(8):542–549. doi: 10.1136/jclinpath-2019-205818

Figure 4.

Figure 4

Kaplan–Meier analysis of the disease-free survival (A) and overall survival of (B) of patients with advanced oropharyngeal squamous cell carcinoma. p16+ or p16 status combined with programmed death ligand 1 (PD-L1)+ or PD-L1 immune cells (IC-PD-L1). Significant differences were evaluated using a log-rank test.